Ph.D., Professor, UCSF
Biography
Dr. Wu's research involves pharmacogenomics, cardiac biomarkers and clinical toxicology. With the onset of the COVID-19 pandemic, he has switch his focus towards molecular testing for the virus, antigen and antibodies after an infection and after a vaccine. Throughout his career, he has been a leader in promoting the value of clinical laboratory testing to the medical world, but especially the lay public. During the early months of the pandemic, the absence lab testing availability was directly linked to the spread of the virus.
Session Abstract – PMWC 2022 Silicon Valley
Track 1 - June 28 11.00 A.M.-11.45 A.M.
This panel will discuss the current state of affairs for virus testing including genotyping, antigen testing including limitations, and the value for antibody testing including total, virus neutralization, and surrogate neutralization testing in light of COVID variants. Also cover home testing options and limitations.
